Lactobacillus gasseri for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Lactobacillus gasseri for Health & Longevity

Created on 07/15/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

Lactobacillus gasseri is a gut and vaginal probiotic taken mainly for weight and digestive support. Its clearest effect is a modest reduction in belly fat with two specific strains used daily for about three months. Sleep, stress, vaginal balance, and cholesterol effects are promising but less certain. Benefits fade after stopping. (Full Review)

Protocol

Dose
Once daily
About 10⁹–10¹⁰ CFU per day, typically with a meal
Duration
8–12 weeks minimum
Continuous daily use needed; effects fade on stopping
Strain
Match to goal
SBT2055 or BNR17 for metabolic; heat-inactivated CP2305 for stress and sleep
Time to effect
Abdominal fat
8–12 weeks
Fair evaluation needs two to three months
Sleep & stress
Sooner
May be noticed somewhat earlier than metabolic effects
After stopping
~1 month
Abdominal-fat benefit returns toward baseline

Benefits

Contraindications
  • Severe immunosuppression (chemotherapy, transplant recipients)
  • Critical illness
  • Central venous catheter
  • Short bowel syndrome
  • Neutropenia (<500 cells/µL)
    •
Key Interactions
  • Oral antibiotics (amoxicillin, clarithromycin, ciprofloxacin)
  • Immunosuppressants (ciclosporin, tacrolimus, corticosteroids)
  • Antacids and acid-reducers
  • Prebiotic fibers (inulin, fructo-oligosaccharides)
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Transient gastrointestinal symptoms
    •
  • Speculative: Systemic infection in severely immunocompromised individuals; D-lactic acidosis in short bowel syndrome; symptom aggravation in SIBO or histamine intolerance
    •

Monitoring

Marker Target Why
Waist circumference <94 cm (men), <80 cm (women) Tracks the abdominal fat this intervention targets
Body weight / BMI BMI 18.5–24.9 kg/m² Captures the small overall weight change seen in trials
Fasting glucose 70–85 mg/dL Screens for the speculative blood-sugar benefit
Fasting lipid panel (LDL, triglycerides) LDL <100 mg/dL; triglycerides <90 mg/dL Detects any bile-acid-mediated lipid change
hs-CRP <1.0 mg/L Reflects the low-grade inflammation the gut-barrier mechanism may influence

Cadence: Anthropometric and subjective measures at 4 weeks and 8–12 weeks, then every 3–6 months; blood markers every 6–12 months

Qualitative Assessment

  • Sleep quality and time to fall asleep, especially with the CP2305 strain
  • Daytime energy and perceived stress or anxiety
  • Digestive comfort, bloating, and bowel regularity
  • Overall sense of abdominal fullness or waistband fit
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.